Literature DB >> 10807934

The regulator of G protein signaling RGS4 selectively enhances alpha 2A-adreoreceptor stimulation of the GTPase activity of Go1alpha and Gi2alpha.

A Cavalli1, K M Druey, G Milligan.   

Abstract

Agonist-stimulated high affinity GTPase activity of fusion proteins between the alpha(2A)-adrenoreceptor and the alpha subunits of forms of the G proteins G(i1), G(i2), G(i3), and G(o1), modified to render them insensitive to the action of pertussis toxin, was measured following transient expression in COS-7 cells. Addition of a recombinant regulator of G protein signaling protein, RGS4, did not significantly affect basal GTPase activity nor agonist stimulation of the fusion proteins containing Galpha(i1) and Galpha(i3) but markedly enhanced agonist-stimulation of the proteins containing Galpha(i2) and Galpha(o1.) The effect of RGS4 on the alpha(2A)-adrenoreceptor-Galpha(o1) fusion protein was concentration-dependent with EC(50) of 30 +/- 3 nm and the potency of the receptor agonist UK14304 was reduced 3-fold by 100 nm RGS4. Equivalent reconstitution with Asn(88)-Ser RGS4 failed to enhance agonist function on the alpha(2A)-adrenoreceptor-Galpha(o1) or alpha(2A)-adrenoreceptor-Galpha(i2) fusion proteins. Enzyme kinetic analysis of the GTPase activity of the alpha(2A)-adrenoreceptor-Galpha(o1) and alpha(2A)-adrenoreceptor-Galpha(i2) fusion proteins demonstrated that RGS4 both substantially increased GTPase V(max) and significantly increased K(m) of the fusion proteins for GTP. The increase in K(m) for GTP was dependent upon RGS4 amount and is consistent with previously proposed mechanisms of RGS function. Agonist-stimulated GTPase turnover number in the presence of 100 nm RGS4 was substantially higher for alpha(2A)-adrenoreceptor-Galpha(o1) than for alpha(2A)-adrenoreceptor-Galpha(i2). These studies demonstrate that although RGS4 has been described as a generic stimulator of the GTPase activity of G(i)-family G proteins, selectivity of this interaction and quantitative variation in its function can be monitored in the presence of receptor activation of the G proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10807934     DOI: 10.1074/jbc.M910395199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Endogenous regulators of G protein signaling proteins regulate presynaptic inhibition at rat hippocampal synapses.

Authors:  H Chen; N A Lambert
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-07       Impact factor: 11.205

2.  Differential regulation of G protein-gated inwardly rectifying K(+) channel kinetics by distinct domains of RGS8.

Authors:  S W Jeong; S R Ikeda
Journal:  J Physiol       Date:  2001-09-01       Impact factor: 5.182

3.  Agonist trafficking of G(i/o)-mediated alpha(2A)-adrenoceptor responses in HEL 92.1.7 cells.

Authors:  J P Kukkonen; C C Jansson; K E Akerman
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

4.  A structural determinant that renders G alpha(i) sensitive to activation by GIV/girdin is required to promote cell migration.

Authors:  Mikel Garcia-Marcos; Pradipta Ghosh; Jason Ear; Marilyn G Farquhar
Journal:  J Biol Chem       Date:  2010-02-15       Impact factor: 5.157

5.  Regulation of the avidity of ternary complexes containing the human 5-HT(1A) receptor by mutation of a receptor contact site on the interacting G protein alpha subunit.

Authors:  Philip J Welsby; I Craig Carr; Graeme Wilkinson; Graeme Milligan
Journal:  Br J Pharmacol       Date:  2002-10       Impact factor: 8.739

6.  Regulator of G protein signaling 2 mediates cardiac compensation to pressure overload and antihypertrophic effects of PDE5 inhibition in mice.

Authors:  Eiki Takimoto; Norimichi Koitabashi; Steven Hsu; Elizabeth A Ketner; Manling Zhang; Takahiro Nagayama; Djahida Bedja; Kathleen L Gabrielson; Robert Blanton; David P Siderovski; Michael E Mendelsohn; David A Kass
Journal:  J Clin Invest       Date:  2009-01-05       Impact factor: 14.808

7.  Chronic cold exposure increases RGS7 expression and decreases alpha(2)-autoreceptor-mediated inhibition of noradrenergic locus coeruleus neurons.

Authors:  Hank P Jedema; Stephen J Gold; Guillermo Gonzalez-Burgos; Alan F Sved; Ben J Tobe; Theodore Wensel; Anthony A Grace
Journal:  Eur J Neurosci       Date:  2008-05       Impact factor: 3.386

8.  Activation of an alpha2A-adrenoceptor-Galphao1 fusion protein dynamically regulates the palmitoylation status of the G protein but not of the receptor.

Authors:  Elaine Barclay; Mark O'Reilly; Graeme Milligan
Journal:  Biochem J       Date:  2005-01-01       Impact factor: 3.857

9.  Regulator of G protein signaling 4 [corrected] is a crucial modulator of antidepressant drug action in depression and neuropathic pain models.

Authors:  Maria Stratinaki; Artemis Varidaki; Vasiliki Mitsi; Subroto Ghose; Jane Magida; Caroline Dias; Scott J Russo; Vincent Vialou; Barbara J Caldarone; Carol A Tamminga; Eric J Nestler; Venetia Zachariou
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-29       Impact factor: 11.205

10.  Src phosphorylation of micro-receptor is responsible for the receptor switching from an inhibitory to a stimulatory signal.

Authors:  Lei Zhang; Hui Zhao; Yu Qiu; Horace H Loh; Ping-Yee Law
Journal:  J Biol Chem       Date:  2008-11-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.